ID: ALA4160638

Max Phase: Preclinical

Molecular Formula: C49H58N8O5

Molecular Weight: 839.05

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCn1cc(C[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC)C(=O)N[C@@H](CC(C)C)C(N)=O)c2ccccc21

Standard InChI:  InChI=1S/C49H58N8O5/c1-5-57-30-35(37-21-13-15-23-44(37)57)28-43(48(61)53-39(45(50)58)24-31(2)3)56-47(60)41(26-33-18-10-7-11-19-33)54-49(62)42(27-34-29-52-38-22-14-12-20-36(34)38)55-46(59)40(51-4)25-32-16-8-6-9-17-32/h6-23,29-31,39-43,51-52H,5,24-28H2,1-4H3,(H2,50,58)(H,53,61)(H,54,62)(H,55,59)(H,56,60)/t39-,40+,41-,42+,43+/m0/s1

Standard InChI Key:  BVTULTCQCHBZMI-UBIIGGBUSA-N

Associated Targets(Human)

NCI-H69 709 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DMS-79 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 839.05Molecular Weight (Monoisotopic): 838.4530AlogP: 4.47#Rotatable Bonds: 21
Polar Surface Area: 192.24Molecular Species: NEUTRALHBA: 7HBD: 7
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.94CX Basic pKa: 8.34CX LogP: 5.56CX LogD: 4.57
Aromatic Rings: 6Heavy Atoms: 62QED Weighted: 0.06Np Likeness Score: -0.15

References

1. Haitham Abusara O, Freeman S, Aojula HS..  (2017)  Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain.,  137  [PMID:28595067] [10.1016/j.ejmech.2017.05.053]

Source